Geneva Capital Management LLC Acquires 39,877 Shares of Balchem Co. (NASDAQ:BCPC)

Geneva Capital Management LLC raised its stake in Balchem Co. (NASDAQ:BCPC - Free Report) by 5.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 819,746 shares of the basic materials company's stock after purchasing an additional 39,877 shares during the period. Balchem accounts for approximately 2.3% of Geneva Capital Management LLC's investment portfolio, making the stock its 11th biggest position. Geneva Capital Management LLC owned approximately 2.52% of Balchem worth $133,615,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Arizona State Retirement System boosted its holdings in shares of Balchem by 0.8% during the 4th quarter. Arizona State Retirement System now owns 9,413 shares of the basic materials company's stock worth $1,534,000 after buying an additional 77 shares during the period. Heritage Family Offices LLP boosted its holdings in shares of Balchem by 8.3% during the fourth quarter. Heritage Family Offices LLP now owns 1,420 shares of the basic materials company's stock worth $231,000 after acquiring an additional 109 shares during the period. Inspire Investing LLC grew its position in shares of Balchem by 4.9% in the fourth quarter. Inspire Investing LLC now owns 2,462 shares of the basic materials company's stock valued at $401,000 after purchasing an additional 114 shares during the last quarter. Westside Investment Management Inc. bought a new position in shares of Balchem during the third quarter worth approximately $27,000. Finally, SageView Advisory Group LLC lifted its holdings in Balchem by 3.8% during the 3rd quarter. SageView Advisory Group LLC now owns 4,653 shares of the basic materials company's stock worth $819,000 after purchasing an additional 169 shares during the last quarter. 87.91% of the stock is owned by institutional investors.

Remove Ads

Balchem Price Performance

Balchem stock traded down $5.10 during mid-day trading on Monday, reaching $170.59. 273,423 shares of the company were exchanged, compared to its average volume of 138,889. The company has a fifty day simple moving average of $163.17 and a 200-day simple moving average of $169.84. The firm has a market cap of $5.55 billion, a PE ratio of 43.41, a PEG ratio of 4.41 and a beta of 0.63. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.99 and a quick ratio of 1.16. Balchem Co. has a 12 month low of $137.69 and a 12 month high of $186.03.

Balchem (NASDAQ:BCPC - Get Free Report) last posted its quarterly earnings results on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing analysts' consensus estimates of $1.11 by ($0.08). The company had revenue of $240.00 million during the quarter, compared to analyst estimates of $239.96 million. Balchem had a net margin of 13.47% and a return on equity of 11.37%. As a group, equities research analysts expect that Balchem Co. will post 4.64 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on BCPC shares. Sidoti raised Balchem to a "hold" rating in a report on Tuesday, February 25th. HC Wainwright reaffirmed a "buy" rating and set a $190.00 price target on shares of Balchem in a research report on Monday, February 24th. Finally, StockNews.com cut shares of Balchem from a "buy" rating to a "hold" rating in a research note on Tuesday, February 25th.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.